PROVIDER PROFILE · NPI 1750430823

Mark StesinM.D.

PRACTICEMARK P STESIN MD PASee all providers at this practice →

EndocrinologyRobbinsdale, MNI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

469

Unique beneficiaries

—

Total services

940

Distinct HCPCS

Medicare payment

$72K

Peer benchmark

Total Medicare services vs. 130 Endocrinology providers in MN — above median (cohort median 631).

PRESCRIBING · PART D · 2024

Total Rx claims

4,202

Beneficiaries

—

Total drug cost

$1.3M

Distinct drugs

Brand share

42.1%

Top prescribed drugs

Levothyroxine Sodium987 claims

Levothyroxine Sodium456 claims

Empagliflozin271 claims

Metformin Hcl228 claims

Semaglutide178 claims

QUALITY · MIPS · 2024

Final MIPS score

22.9

Quality

0.0

Cost

76.5

Improvement activities

0.0

Promoting interop.

0.0

Payment adjustment

-6.25%

Individual

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$796

Payment records

By payment type

Food and Beverage$776

Travel and Lodging$20

REFERRAL NETWORK

Where Mark Stesin's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
NPI 1083760789	173	557
FAIRVIEW HEALTH SERVICES	16	46
Hennepin Healthcare System, Inc Opioid Treatment Program · Minneapolis, MN	16	74
MAPLE GROVE HOSPITAL CORPORATION	11	22

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history